Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial - Concepedia

Concepedia

Publication | Open Access

Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial

DOI Full Paper Access

25

Citations

16

References

2025

Year

Ali A. Habib, Chongbo Zhao, Inmaculada Aban, Marcondes C. França, Jorge Gustavo José, Gerd Meyer zu Hörste, Elzbieta Klimiec, Michael Pulley, Darío Tavolini, Petranka Krumova,

The Lancet Neurology

Abstract

F Hoffmann La Roche.

References

	Year	Citations

Page 1